| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 |
| filingDate |
2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80039df77c8f23c166dab374d6ce5c67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db8b479db971d99d832a456b8249ba1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06edd76f224260a697febd4099587a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1454fc74b644247baeb1914f97a5f577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c029585627aebbb88f5e70af0d7fe3ae |
| publicationDate |
2009-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CL-2008003822-A1 |
| titleOfInvention |
Compounds derived from n1- (2-thiazolyl) -1,2-dicarboxamide pyrrolidine; preparation procedure; pharmaceutical composition; pharmaceutical combination; and use for the treatment of diseases ameliorated by phosphatidylinositol-3-kinase inhibition, such as cancer. |
| abstract |
Compounds derived from 2-carboxamide cyanoaminourea; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound for the treatment of diseases ameliorated by phosphatylinositol 3-kinase inhibition, such as cancer. |
| priorityDate |
2007-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |